Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155358 | SCV000205045 | benign | not specified | 2012-05-07 | criteria provided, single submitter | clinical testing | "Pro297Pro in Exon 09 of DIAPH1: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue, is not located with in the splice consensus sequence, and has been identified in 1.1% (35/3096) of A frican American chromosomes from a broad population by the NHLBI Exome Sequencin g Project (http://evs.gs.washington.edu/EVS; dbSNP rs116463365)." |
Invitae | RCV000530079 | SCV000655972 | benign | Autosomal dominant nonsyndromic hearing loss 1; Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000155358 | SCV001476413 | benign | not specified | 2020-07-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001698660 | SCV001916698 | benign | not provided | 2020-03-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003937461 | SCV004752196 | benign | DIAPH1-related disorder | 2019-08-01 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |